ARROWHEAD PHARMACEUTICALS, INC. financial data

Symbol
ARWR on Nasdaq
Location
Pasadena, CA
Fiscal year end
30 September
Latest financial report
10-K - Q3 2025 - 25 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 512% % -13%
Return On Equity -0.37% % 100%
Return On Assets -0.12% % 100%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 135,809,558 shares 7.7%
Common Stock, Shares, Outstanding 135,702,000 shares 9.1%
Entity Public Float $1,400,000,000 USD -53%
Common Stock, Value, Issued $231,000 USD 6.5%
Weighted Average Number of Shares Outstanding, Basic 133,758,000 shares 12%
Weighted Average Number of Shares Outstanding, Diluted 133,758,000 shares 12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $829,448,000 USD 23258%
General and Administrative Expense $123,943,000 USD 25%
Operating Income (Loss) $98,346,000 USD
Nonoperating Income (Expense) $46,813,000 USD -311%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $51,533,000 USD
Income Tax Expense (Benefit) $4,729,233 USD
Net Income (Loss) Attributable to Parent $1,631,000 USD 100%
Earnings Per Share, Basic 0 USD/shares 100%
Earnings Per Share, Diluted 0 USD/shares 100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $69,400,000 USD -34%
Accounts Receivable, after Allowance for Credit Loss, Current $6,824,000 USD
Other Assets, Current $13,516,000 USD 172%
Assets, Current $950,639,000 USD 37%
Property, Plant and Equipment, Net $382,515,000 USD -0.91%
Operating Lease, Right-of-Use Asset $43,891,000 USD -3%
Other Assets, Noncurrent $1,389,000 USD -69%
Assets $1,385,295,000 USD 22%
Accounts Payable, Current $17,674,000 USD 55%
Employee-related Liabilities, Current $26,895,000 USD 22%
Accrued Liabilities, Current $90,419,000 USD 43%
Contract with Customer, Liability, Current $2,399,000 USD
Liabilities, Current $195,487,000 USD 89%
Operating Lease, Liability, Noncurrent $104,112,000 USD -6.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,443,000 USD 36%
Retained Earnings (Accumulated Deficit) $1,627,154,000 USD -0.1%
Stockholders' Equity Attributable to Parent $466,052,000 USD 151%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $503,416,000 USD 163%
Liabilities and Equity $1,385,295,000 USD 22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $146,272,000 USD -24%
Net Cash Provided by (Used in) Financing Activities $20,634,000 USD 7628%
Net Cash Provided by (Used in) Investing Activities $76,910,000 USD 19%
Common Stock, Shares Authorized 290,000,000 shares 0%
Common Stock, Shares, Issued 135,702,000 shares 9.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $226,548,000 USD 121%
Deferred Tax Assets, Valuation Allowance $497,543,000 USD 11%
Deferred Tax Assets, Gross $562,686,000 USD 19%
Operating Lease, Liability $111,401,000 USD -5.1%
Payments to Acquire Property, Plant, and Equipment $7,516,000 USD -89%
Lessee, Operating Lease, Liability, to be Paid $173,558,000 USD -7.9%
Property, Plant and Equipment, Gross $462,684,000 USD 4.2%
Operating Lease, Liability, Current $7,289,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $15,050,000 USD -4.7%
Lessee, Operating Lease, Liability, to be Paid, Year One $15,873,000 USD 2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $62,157,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Three $13,696,000 USD -8.5%
Deferred Tax Assets, Operating Loss Carryforwards $70,858,000 USD -31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $22,152,000 USD 33%
Lessee, Operating Lease, Liability, to be Paid, Year Four $13,985,000 USD 2.7%
Operating Lease, Payments $15,474,000 USD 40%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $1,700,000 USD 0%
Depreciation, Depletion and Amortization $22,200,000 USD 31%
Share-based Payment Arrangement, Expense $54,848,000 USD -18%
Interest Expense $23,031,000 USD 43%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%